Antiverse
Cardiff, United Kingdom · antiverse.io
Antiverse discovers developable, functional biologics for GPCRs and other challenging targets using an AI-powered antibody discovery platform. It works with partners in biotechnology and pharma from its base in Cardiff, United Kingdom.
They take quote requests by email.
What they offer
De novo antibody and nanobody discovery
Generates antibody and nanobody sequences de novo from target sequence alone, without requiring an existing ligand, binder, or prior campaign data.
Generative AI design
Uses generative AI to design biologics from target sequence alone and explore novel chemical space, sequence, or structure-based designs.
Native membrane screening
Pans candidates against target receptors expressed in precisely engineered cell lines in their native membrane environment.
Functional validation
Runs cell-based functional assays to confirm agonist, antagonist, or modulator activity against disease-relevant receptors.
Developability triage
Clusters binders by epitope and developability properties to return a diverse, developable panel.
AI and ML-guided binder discovery
Uses proprietary AI and ML models to identify high-potential binders for challenging GPCR and transmembrane targets.
What they work on
- Modalities
- Antibody
- Assays and studies
- functional assays, cell-based functional assays, native membrane screening, epitope-specific functional prediction
- Therapeutic areas
- GPCRs, transmembrane targets
- Turnaround
- 1 month
- Sites
- Cardiff, United Kingdom
- Founded
- 2017
Similar labs. 2TLab, 3C Therapeutics, 64x, AbboMax
Found in a contract services directory. Listing built from antiverse.io. Work here? Claim this listing.